STOCK TITAN

[Form 4] Lifevantage Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Lifevantage Corp (LFVN) Chief Financial Officer Carl Aure received equity awards on 08/26/2025. The Form 4 reports an award of 10,241 stock units that represent rights to receive common shares and 15,361 Performance Restricted Stock Units (PRSUs) that are earned based on specified financial performance criteria. After the reported transactions, the filing shows 143,544 shares beneficially owned and 15,361 derivative shares from PRSUs. The stock units vest over time with a schedule beginning September 10, 2026, and the PRSUs vest contingent on performance and continued service with vesting dates in 2026–2028. The form was signed by power of attorney on 08/28/2025.

Il Chief Financial Officer di Lifevantage Corp (LFVN), Carl Aure, ha ricevuto premi in azioni il 26/08/2025. Il Modulo 4 segnala un premio di 10.241 unità azionarie che rappresentano il diritto a ricevere azioni ordinarie e 15.361 Performance Restricted Stock Units (PRSUs) acquisibili al raggiungimento di determinati obiettivi finanziari. Dopo le operazioni riportate, la dichiarazione indica la detenzione effettiva di 143.544 azioni e 15.361 azioni derivate derivanti dalle PRSU. Le unità azionarie maturano secondo un piano con decorrenza il 10 settembre 2026, mentre le PRSU maturano al verificarsi delle condizioni di performance e del mantenimento dell’incarico, con date di maturazione tra il 2026 e il 2028. Il modulo è stato firmato per procura il 28/08/2025.

Carl Aure, Director Financiero de Lifevantage Corp (LFVN), recibió adjudicaciones de acciones el 26/08/2025. El Formulario 4 informa una adjudicación de 10.241 unidades de acciones que representan derechos a recibir acciones ordinarias y 15.361 Performance Restricted Stock Units (PRSUs) que se obtienen según criterios financieros específicos. Tras las operaciones notificadas, la presentación muestra la titularidad beneficiaria de 143.544 acciones y 15.361 acciones derivadas por las PRSU. Las unidades de acciones se consolidan según un calendario que comienza el 10 de septiembre de 2026, y las PRSU dependen del rendimiento y la continuidad en el puesto, con fechas de consolidación entre 2026 y 2028. El formulario fue firmado por poder el 28/08/2025.

Lifevantage Corp(LFVN) 최고재무책임자(CFO) 칼 오어(Carl Aure)가 2025년 8월 26일에 주식 보상을 받았습니다. Form 4는 보통주를 수령할 권리를 나타내는 10,241단위의 주식 단위와 특정 재무 성과 기준에 따라 취득되는 15,361개의 성과제한주식단위(PRSUs)를 보고하고 있습니다. 보고된 거래 이후 제출서는 143,544주의 실질 보유와 PRSU로 인한 15,361주의 파생 주식을 표시합니다. 주식 단위는 2026년 9월 10일부터 시작되는 일정에 따라 서서히 권리가 부여되며, PRSU는 성과 및 계속 근무 조건에 따라 2026년–2028년 사이에 권리가 부여됩니다. 해당 서류는 2025년 8월 28일 위임장으로 서명되었습니다.

Le directeur financier de Lifevantage Corp (LFVN), Carl Aure, a reçu des attributions d'actions le 26/08/2025. Le formulaire 4 rapporte une attribution de 10 241 unités d'actions représentant des droits à recevoir des actions ordinaires et 15 361 Performance Restricted Stock Units (PRSUs) qui sont acquises en fonction de critères de performance financière spécifiés. Après les opérations déclarées, le dépôt indique une détention bénéficiaire de 143 544 actions et 15 361 actions dérivées provenant des PRSUs. Les unités d'actions acquièrent des droits selon un calendrier débutant le 10 septembre 2026, tandis que les PRSUs sont soumises aux conditions de performance et de maintien du poste, avec des dates d'acquisition entre 2026 et 2028. Le formulaire a été signé par procuration le 28/08/2025.

Lifevantage Corp (LFVN) Finanzvorstand Carl Aure erhielt am 26.08.2025 Aktienzuwendungen. Das Formular 4 meldet eine Zuwendung von 10.241 Aktieneinheiten, die das Recht auf den Erhalt von Stammaktien darstellen, sowie 15.361 Performance Restricted Stock Units (PRSUs), die bei Erreichen bestimmter finanzieller Leistungsziele verdient werden. Nach den gemeldeten Transaktionen weist die Einreichung einen wirtschaftlichen Besitz von 143.544 Aktien und 15.361 derivativen Aktien aus PRSUs aus. Die Aktieneinheiten werden nach einem Plan mit Beginn am 10. September 2026 vesten, die PRSUs vesten abhängig von Leistungskriterien und fortlaufender Dienstzeit mit Vesting-Terminen zwischen 2026 und 2028. Das Formular wurde am 28.08.2025 per Vollmacht unterzeichnet.

Positive
  • Grant disclosed: Reporting shows receipt of 10,241 stock units and 15,361 PRSUs on 08/26/2025
  • Clear vesting schedules: Stock units vest beginning 09/10/2026; PRSUs vest in 2026–2028 subject to performance
  • Ownership increase documented: Beneficial ownership reported as 143,544 common shares and 15,361 PRSU-linked shares
Negative
  • None.

Insights

TL;DR: CFO received time-based and performance-based equity grants, increasing direct and potential holdings.

The filing documents a combined grant of 10,241 stock units and 15,361 PRSUs to the CFO on 08/26/2025, increasing reported beneficial ownership to 143,544 shares plus 15,361 PRSU-linked shares. The stock units vest beginning 09/10/2026 in a defined installment schedule, while PRSU vesting depends on achieving stated financial performance targets with vesting in 2026–2028. For investors, these awards reflect compensation alignment with future performance milestones and retention through multi-year vesting.

TL;DR: The Form 4 discloses standard executive equity compensation with specified vesting and performance conditions.

The report identifies Carl Aure as an officer (CFO) and details equity awards executed 08/26/2025: 10,241 stock units (time-based vesting schedule) and 15,361 PRSUs (performance-contingent, eligible up to 200% of target at maximum). Vesting schedules and performance conditions are explicitly stated, and the disclosure was executed by a power of attorney on 08/28/2025. This is a routine, governance-compliant disclosure of insider compensation and resulting beneficial ownership.

Il Chief Financial Officer di Lifevantage Corp (LFVN), Carl Aure, ha ricevuto premi in azioni il 26/08/2025. Il Modulo 4 segnala un premio di 10.241 unità azionarie che rappresentano il diritto a ricevere azioni ordinarie e 15.361 Performance Restricted Stock Units (PRSUs) acquisibili al raggiungimento di determinati obiettivi finanziari. Dopo le operazioni riportate, la dichiarazione indica la detenzione effettiva di 143.544 azioni e 15.361 azioni derivate derivanti dalle PRSU. Le unità azionarie maturano secondo un piano con decorrenza il 10 settembre 2026, mentre le PRSU maturano al verificarsi delle condizioni di performance e del mantenimento dell’incarico, con date di maturazione tra il 2026 e il 2028. Il modulo è stato firmato per procura il 28/08/2025.

Carl Aure, Director Financiero de Lifevantage Corp (LFVN), recibió adjudicaciones de acciones el 26/08/2025. El Formulario 4 informa una adjudicación de 10.241 unidades de acciones que representan derechos a recibir acciones ordinarias y 15.361 Performance Restricted Stock Units (PRSUs) que se obtienen según criterios financieros específicos. Tras las operaciones notificadas, la presentación muestra la titularidad beneficiaria de 143.544 acciones y 15.361 acciones derivadas por las PRSU. Las unidades de acciones se consolidan según un calendario que comienza el 10 de septiembre de 2026, y las PRSU dependen del rendimiento y la continuidad en el puesto, con fechas de consolidación entre 2026 y 2028. El formulario fue firmado por poder el 28/08/2025.

Lifevantage Corp(LFVN) 최고재무책임자(CFO) 칼 오어(Carl Aure)가 2025년 8월 26일에 주식 보상을 받았습니다. Form 4는 보통주를 수령할 권리를 나타내는 10,241단위의 주식 단위와 특정 재무 성과 기준에 따라 취득되는 15,361개의 성과제한주식단위(PRSUs)를 보고하고 있습니다. 보고된 거래 이후 제출서는 143,544주의 실질 보유와 PRSU로 인한 15,361주의 파생 주식을 표시합니다. 주식 단위는 2026년 9월 10일부터 시작되는 일정에 따라 서서히 권리가 부여되며, PRSU는 성과 및 계속 근무 조건에 따라 2026년–2028년 사이에 권리가 부여됩니다. 해당 서류는 2025년 8월 28일 위임장으로 서명되었습니다.

Le directeur financier de Lifevantage Corp (LFVN), Carl Aure, a reçu des attributions d'actions le 26/08/2025. Le formulaire 4 rapporte une attribution de 10 241 unités d'actions représentant des droits à recevoir des actions ordinaires et 15 361 Performance Restricted Stock Units (PRSUs) qui sont acquises en fonction de critères de performance financière spécifiés. Après les opérations déclarées, le dépôt indique une détention bénéficiaire de 143 544 actions et 15 361 actions dérivées provenant des PRSUs. Les unités d'actions acquièrent des droits selon un calendrier débutant le 10 septembre 2026, tandis que les PRSUs sont soumises aux conditions de performance et de maintien du poste, avec des dates d'acquisition entre 2026 et 2028. Le formulaire a été signé par procuration le 28/08/2025.

Lifevantage Corp (LFVN) Finanzvorstand Carl Aure erhielt am 26.08.2025 Aktienzuwendungen. Das Formular 4 meldet eine Zuwendung von 10.241 Aktieneinheiten, die das Recht auf den Erhalt von Stammaktien darstellen, sowie 15.361 Performance Restricted Stock Units (PRSUs), die bei Erreichen bestimmter finanzieller Leistungsziele verdient werden. Nach den gemeldeten Transaktionen weist die Einreichung einen wirtschaftlichen Besitz von 143.544 Aktien und 15.361 derivativen Aktien aus PRSUs aus. Die Aktieneinheiten werden nach einem Plan mit Beginn am 10. September 2026 vesten, die PRSUs vesten abhängig von Leistungskriterien und fortlaufender Dienstzeit mit Vesting-Terminen zwischen 2026 und 2028. Das Formular wurde am 28.08.2025 per Vollmacht unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aure Carl

(Last) (First) (Middle)
3300 N. TRIUMPH BLVD
SUITE 700

(Street)
LEHI UT 84043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 08/26/2025 A 10,241 A $0 143,544 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Restricted Stock Units(2) (3) 08/26/2025 A V 15,361 (3) (3) Common Stock 15,361 $0 15,361 D
Explanation of Responses:
1. This reflects a stock unit award, in which each stock unit represents a right to receive one share of issuer common stock, which award will vest, subject to the reporting person's continued service with the issuer, as follows: (i) 5/12 of the total number of units will vest on September 10, 2026 and (ii) the remaining units will vest in equal installments as of the 10th day of the third month of each of the seven calendar quarters thereafter.
2. Each Performance Restricted Stock Unit ("PRSU") represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units.
3. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.
Remarks:
/s/ Alissa Neufeld, Power of Attorney for Carl Aure 08/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LFVN CFO Carl Aure receive on 08/26/2025?

The Form 4 reports receipt of 10,241 stock units and 15,361 Performance Restricted Stock Units (PRSUs) on 08/26/2025.

How many shares does Carl Aure beneficially own after the reported transactions?

The filing shows 143,544 shares beneficially owned following the reported non-derivative transaction and 15,361 derivative shares tied to PRSUs.

When do the awarded stock units and PRSUs vest?

Stock units vest beginning September 10, 2026 (5/12 of total then, remainder in equal installments over seven calendar quarters). PRSUs vest based on performance with vesting on September 10, 2026, September 10, 2027, and September 10, 2028 for earned portions.

Are the PRSUs performance-contingent and can they pay more than target?

Yes. Each PRSU is earned based on specified financial performance criteria and may pay up to 200% of target if maximum performance is achieved.

Who signed the Form 4 and when?

The Form 4 was signed by Alissa Neufeld as Power of Attorney for Carl Aure on 08/28/2025.
Lifevantage Corp

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

168.81M
10.52M
15.23%
65.86%
18.78%
Packaged Foods
Pharmaceutical Preparations
Link
United States
LEHI